FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Anixa Gains IND Approval of CAR-T for Ovarian Cancer

FDA approves an Anixa Biosciences IND for its CAR-T (Chimeric Antigen Receptor-T cell) therapy and its use in treating ovarian cancer.

Guide Revised on Trials Conducted During Covid

FDA revises its guidance entitled Conduct of Clinical Trials of Medical Products During the Covid-19 Public Health Emergency.

Medical Devices

De Novo Granted for Smart Knee Replacement

FDA grants a de novo authorization to Zimmer Biomet and Canary Medical for their tibial extension for Persona IQ, the first smart knee for total knee ...

Human Drugs

Lantern Pharma Gets Orphan Status LP-184

FDA grants Lantern Pharma an orphan drug designation for LP-184 and its use in treating glioblastoma multiforme and other malignant gliomas.

Federal Register

EUA Withdrawn for Curative Covid Assay

Federal Register notice: FDA announces that it has revoked the Emergency Use Authorization issued to Curative Inc. for its Curative SARS-Cov-2 Assay b...

Federal Register

2 Guides on Device Performance Based Pathway

Federal Register notice: FDA makes available two draft device-specific guidance documents for the Safety and Performance Based Pathway one on denture...

Federal Register

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 8/27/2021.

Human Drugs

Since Our Last Issue ...

Industry news you may have missed since our last issue.

FDA General

Product Approval Summaries

FDA Review posts product approval summaries for the week ending 8/27/2021.

Human Drugs

Roche Drops Tecentriq Breast Cancer Indication

Roche withdraws its accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy for treating adults with unresectable locally a...